Vectura Group Share Price (VEC)

0.00 0.00 (0.00%) delayed: 5:44AM GMT
Bid price 0.00 Open price 0.00
Ask price 0.00 Prev close 146.00
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index n/a

Vectura Group Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) -0.13
Market Capitalisation (£m) 580.57 Gross Gearing (%) 26.40
Shares in issue (m) 402.48 Debt Ratio 22.10
P/E Ratio -206.07 Debt-to-Equity Ratio 0.79
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.36
Dividend Yield (%) 0.00 Price to book value 2.56
Dividend cover (x) 0.00 ROCE -0.03
Earning per share (p) -0.70 EPS Growth (%) 61.11
52 week high / low 169.50 / 113.75 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
16/01/2015 EXR Dr Trevor Phillips ED 3,133
16/01/2015 EXR Dr Trevor Phillips ED 208,877
16/01/2015 SEXR Dr Trevor Phillips ED 171,777
08/07/2014 BUY Dr Christopher Blackwell CEO 1,212
08/07/2014 BUY Dr Trevor Phillips ED 1,212

More Vectura Group Director Deals >>

Vectura Group Company News

14:19 10/02/2015

Holding(s) in Company

/* */ RNS Number : 5477E Vectura Group plc 10 February 2015      For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST...

07:11 03/02/2015

FLASH: Vectura's CEO Chris Blackwell to step down

Story provided by

07:00 03/02/2015

Chief Executive's intention to step down

/* */ RNS Number : 8380D Vectura Group plc 03 February 2015    Vectura Group plc   Vectura Group announces Chief Executive's intention to step down     Chippenham, UK - 3 February 2015: Vectura Group plc   (LSE: VEC;...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

1 months ago


Powered by IST's

Register now for FREE Vectura Group share price discussions